The Conversation (0)
December 12, 2023
Elixir Energy Limited (Elixir or the Company) is pleased to announce that it has received binding bids for a placement of new shares in the Company (Placement), on the following terms:
1. Placement to raise $6.5 million (before costs) through the issue of ~76 million new shares to institutional and sophisticated investors at a price of 8.5 cents per share (a 15% discount to the last close and a 17% discount to the 5 day VWAP).
2. Placement participants will receive one (1) of Elixir’s currently listed options (EXROB) for every three (3) Placement Shares issued. The EXROB Options have an exercise price of 12 cents and a term expiring on 17 October 2026.
HIGHLIGHTS
- Share placement of $6.5 million to institutional and sophisticated investors
- Funds primarily to be used to expand imminent Daydream-2 stimulation and testing program
Taylor Collison Limited and Originate Capital Pty Ltd acted as Joint Lead Managers to the Placement.
Given a share purchase plan (SPP) was offered to shareholders less than 3 months ago, the Company has decided not to repeat an SPP offer at this time.
The new capital raised will primarily be used to expand the multiple stage stimulation and flow testing program at the Company’s Daydream-2 well, including pursuing new options arising from the recent free gas flow announced on 7 December 2023.
The new shares are anticipated to be issued on 19 December 2023.
Elixir’s Managing Director, Mr. Neil Young, said: “Following last week’s very exciting news of free flowing gas from Daydream-2, we are pleased to procure this financial backing from existing and new shareholders. Although our balance sheet is in good shape anyway, this raising will allow us to aggressively pursue an expansion of the stimulation and testing plans at Daydream-2”.
Click here for the full ASX Release
This article includes content from Elixir Energy, licensed for the purpose of publishing on Investing News Australia. This article does not constitute financial product advice. It is your responsibility to perform proper due diligence before acting upon any information provided here. Please refer to our full disclaimer here.
EXR:AU
02 May 2024
Elixir Energy
Early-mover in natural gas exploration and appraisal in Australia and Mongolia.
Early-mover in natural gas exploration and appraisal in Australia and Mongolia. Keep Reading...
21h
Quarterly Activities/Appendix 4C Cash Flow Report
MEC Resources (MMR:AU) has announced Quarterly Activities/Appendix 4C Cash Flow ReportDownload the PDF here. Keep Reading...
23h
Is Now a Good Time to Invest in Oil Stocks?
Investing in oil stocks can be a lucrative endeavor, but determining the right time to enter a sector known for volatile swings can be tricky.Over the past five years, the oil market’s inherent volatility has been on clear display. Major declines in consumption brought on by the COVID-19... Keep Reading...
28 January
December 2025 Quarterly Report and Appendix 4C
BPH Energy (BPH:AU) has announced December 2025 Quarterly Report and Appendix 4CDownload the PDF here. Keep Reading...
27 January
Syntholene Energy Corp. Announces Issuance of Key U.S. Patent Covering Proprietary Fuel Synthesis Reactor
Newly granted patent represents a foundational innovation, engineered to deliver high-yield, low-cost, and ultra-pure synthetic fuels, including eSAFSyntholene Energy Corp. (TSXV: ESAF) (FSE: 3DD0) ("Syntholene" or the "Company") announces the issuance of its first U.S. Patent granted by the... Keep Reading...
23 January
Chevron Reportedly Targeting Q1 Sale of Singapore Refining and Fuel Assets
Chevron (NYSE:CVX) is moving toward the exit from its downstream footprint in Singapore, with the US oil major aiming to finalize the sale of its refining and fuel distribution assets in the first quarter of the year.According to a Reuters exclusive, four people familiar with the matter said the... Keep Reading...
Latest News
Interactive Chart
Latest Press Releases
Related News
TOP STOCKS
American Battery4.030.24
Aion Therapeutic0.10-0.01
Cybin Corp2.140.00